Article Text

Download PDFPDF
Ruptured mycotic coronary artery aneurysm
  1. Scott E Janus1,
  2. Sadeer Al-Kindi2,
  3. Graham Pollock3 and
  4. Steven Laster4
  1. 1Cardiology, University Hospitals Case Medical Center, Cleveland, Ohio, USA
  2. 2Harrington Heart and Vascular Institute, University Hospitals, Cleveland, Ohio, USA
  3. 3St Luke’s Mid America Heart Institute, St Luke’s Hospital, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA
  4. 4University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA
  1. Correspondence to Dr Scott E Janus; sejanus2{at}


Aneurysms complicated by rupture of the coronary arteries are exceedingly rare. Literature regarding management of mycotic aneurysms resulting in rupture is limited. Therefore, we describe a fascinating diagnosis, imaging progression and management of a ruptured mycotic coronary artery aneurysm.

  • Interventional cardiology
  • Infectious diseases
  • Rheumatology
  • Vasculitis
  • Pericardial disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors SJ and SL contributed equally to the writing and editing of this manuscript. SJ is the lead author, while SL is the corresponding author. SL is an interventional cardiologist, while SJ is an interventional cardiology fellow. Both SL and SJ provided critical appraisal of the final article. SA-K and GP provided further editing and review of the manuscript. SA-K is a non-invasive cardiologist, while GP is a cardiothoracic surgeon.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.